TWD 27.9
(0.54%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 50.55 Million TWD | -56.26% |
2022 | 115.58 Million TWD | -42.42% |
2021 | 200.73 Million TWD | 90.99% |
2020 | 105.1 Million TWD | 1774.7% |
2019 | -6.27 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -92.62 Million TWD | 3.39% |
2024 Q1 | -91.03 Million TWD | -280.07% |
2023 FY | 50.55 Million TWD | -56.26% |
2023 Q2 | 63.97 Million TWD | 8.39% |
2023 Q1 | 59.02 Million TWD | -48.93% |
2023 Q3 | 45.33 Million TWD | -29.13% |
2023 Q4 | 50.55 Million TWD | 11.5% |
2022 Q3 | 109.36 Million TWD | 0.0% |
2022 Q4 | 115.58 Million TWD | 5.69% |
Name | Net Debt | Net Debt Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | -1.4 Billion TWD | 103.607% |
Bioteque Corporation | -459.67 Million TWD | 110.997% |
Chi Sheng Pharma & Biotech Co., Ltd | -261.04 Million TWD | 119.365% |
Sunder Biomedical Tech. Co., Ltd. | 394.6 Million TWD | 87.189% |
BenQ Medical Technology Corporation | 405.72 Million TWD | 87.54% |
Pacific Hospital Supply Co., Ltd | -307.54 Million TWD | 116.437% |
Unicon Optical Co., Ltd. | 41.06 Million TWD | -23.093% |
Formosa Optical Technology Co.,Ltd. | 2.78 Billion TWD | 98.184% |
Medeon Biodesign, Inc. | -1.19 Billion TWD | 104.245% |
Concord Medical Co., Ltd. | 104.78 Million TWD | 51.755% |
Crystalvue Medical Corporation | -248.31 Million TWD | 120.358% |
ICARES Medicus, Inc. | -259.62 Million TWD | 119.471% |
Lagis Enterprise Co., Ltd. | 87.79 Million TWD | 42.421% |
Amed Co., Ltd. | 153.75 Million TWD | 67.121% |